Search results
Results From The WOW.Com Content Network
Average Annual Total Return, 1973-2023. Dividend growers and initiators. ... Pfizer (NYSE: PFE) has hit a ... but those deliveries offered thin profit margins, ...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024. ... Revenue from COVID products fell to $12.5 billion in 2023, down 78% from the $57 billion of peak in 2022. Analysts expect ...
Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. ... $43 billion acquisition of Seagen in 2023. Management expects Seagen's anti-cancer portfolio to contribute ...
Pfizer shares were off less than 1% in midday trading. Investors fled Pfizer last year as pandemic worries declined and billions of dollars in COVID-19 vaccine and treatment sales disappeared.
The drugmaker said it now expects 2023 revenue of between $58 billion and $61 billion, down from it prior forecast of $67 billion to $70 billion. It said the reduction was solely due to lowered ...
Pfizer now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior forecast of $2.15 to $2.35. ... Pfizer was disappointed with its 2023 launch of RSV shot ...
Image source: The Motley Fool. Pfizer (NYSE: PFE) Q3 2024 Earnings Call Oct 29, 2024, 10:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1. ...